Investigation of the effect of long-acting diquafosol sodium ophthalmic solution on the ocular surface and its usability

Investigation of the effect of long-acting diquafosol sodium ophthalmic solution on the ocular surface and its usability - Investigation of the effect of long-acting diquafosol sodium ophthalmic solution

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000051390

Enrollment

Registered

2023-08-07

Start date

2023-05-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye (DE)

Interventions

Long-acting diquafosol ophthalmic solution

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with dry eye using diquafosol ophthalmic solution

Exclusion criteria

Exclusion criteria: the presence of ocular surgery and trauma within the last 6 months, permanent structural damage due to ocular trauma, receiving pressure-lowering agents for the treatment of glaucoma and current contact lens

Design outcomes

Primary

Measure	Time frame
Clinical findings and usability of ophthalmic solution	—

Countries

Japan

Contacts

Public ContactMinako Kaido

Wada Eye Clinic Ophthalmology

tomoulton777@ff.em-net.ne.jp0335358525

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026